PlainRecalls
FDA Drug Moderate Class II Ongoing

PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21

Reported: July 30, 2025 Initiated: April 21, 2025 #D-0538-2025

Product Description

PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21

Reason for Recall

CGMP Deviations; potential temperature excursions due to transit delays

Details

Units Affected
6 Pre-filled syringes
Distribution
Within the U.S - OH, VA, FL.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 6 Pre-filled syringes.
Why was this product recalled?
CGMP Deviations; potential temperature excursions due to transit delays
Which agency issued this recall?
This recall was issued by the FDA Drug on July 30, 2025. Severity: Moderate. Recall number: D-0538-2025.